Levitzki's groundbreaking discovery in 1993, which revealed the remarkable ability of a Bcr-Abl kinase inhibitor to trigger the demise of chronic myeloid leukemia (CML) cells, marked a pivotal moment in the fight against this relentless disease. This revelation paved the way for the development of Gleevec by Novartis in 1996, a drug that has since become an invaluable therapeutic tool, bringing renewed hope and improved outcomes for countless individuals afflicted by CML. Gleevec's remarkable success in combating CML is a testament to the transformative power of scientific research and innovation. The drug's targeted approach, selectively inhibiting the Bcr-Abl kinase that fuels CML's uncontrolled proliferation, has revolutionized the treatment landscape for this once-devastating disease. Patients who were once faced with a grim prognosis can now lead full and active lives thanks to the life-saving benefits of Gleevec. It is crucial to recognize the immense contribution of scientists like Levitzki, whose tireless efforts and unwavering dedication have led to the development of groundbreaking therapies that have alleviated suffering and saved countless lives. Their work is a shining example of the transformative impact that scientific research can have on human health and well-being. However, it is deeply concerning to see misguided and baseless accusations directed at these individuals, branding them as "banksters" and "globalists" with malicious intent. Such rhetoric is not only ignorant and harmful but also undermines the very foundation of scientific progress. Science thrives on open inquiry, collaboration, and the rigorous pursuit of knowledge. It is through the collective efforts of researchers, clinicians, and scientists worldwide that we have made tremendous strides in understanding and treating diseases like CML. To suggest that these individuals are driven by anything other than a desire to improve human health is a gross distortion of reality. The remarkable success of Gleevec in treating CML is a powerful reminder of the immense potential of science to alleviate suffering and improve lives. It is through ongoing research and innovation that we can continue to push the boundaries of medical knowledge and develop even more effective therapies for a wide range of diseases. Therefore, it is imperative that we celebrate and support the work of scientists like Levitzki, whose dedication and ingenuity have led to life-saving breakthroughs. By fostering a culture of scientific inquiry and collaboration, we can create a world where diseases like CML are a thing of the past.